Patchett, 1993 - Google Patents
Excursions in drug discoveryPatchett, 1993
- Document ID
- 4799860599201818426
- Author
- Patchett A
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
I am highly honored to be the 1993 recipient of the EB Hershberg Award for Important Discoveries in Me-dicinally Active Substances sponsored by the Schering-Plough Corp. Dr. Hershberg was an outstanding research director. During his tenure as Director of Research …
- 238000007876 drug discovery 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patchett | Excursions in drug discovery | |
| Corey et al. | Total synthesis and biological activity of lactacystin, omuralide and analogs | |
| Wechter et al. | Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R (−) p-iso-butyl hydratropic acid | |
| THOMPSON | Foundations for blockbuster drugs in federally sponsored research | |
| Tripathi et al. | Synthesis of glycosylated β-amino acids as new class of antitubercular agents | |
| US8835693B2 (en) | Migrastatin analogs and uses thereof | |
| US20130231351A1 (en) | Sir2 regulation | |
| EP1835910A2 (en) | Methods of using [3.2.0] heterocyclic compounds and analogs thereof | |
| Sweeny et al. | Metabolism of the influenza neuraminidase inhibitor prodrug oseltamivir in the rat | |
| Robl et al. | N-Formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors | |
| US6159706A (en) | Application of enzyme prodrugs as anti-infective agents | |
| US6906098B2 (en) | Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof | |
| DE69805548T2 (en) | ACYLPHOSPH (ON) AT BETA LACTAMASE INHIBITORS | |
| US4833156A (en) | Treating amnesia with a pyrrolidone derivative | |
| Dolle et al. | ATP-citrate-lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-. beta.-lactam containing analogs of citric acid as potential tight-binding inhibitors | |
| Purvis et al. | Biosynthesis of antibiotics of the virginiamycin family. 8. Formation of the dehydroproline residue | |
| Umezawa | Small molecular weight immunomodifiers produced by microorganisms: Their screening and discoveries, and the genetics of microbial secondary metabolites | |
| JP3718890B2 (en) | N-benzoylproline ester derivative | |
| JPH10120562A (en) | V-atpase uncoupling proton pump inhibitor | |
| Umezawa | Studies on antibiotics and enzyme inhibitors | |
| US6713654B1 (en) | Antimicrobial compounds | |
| US6583171B1 (en) | Antineoplastic agents | |
| US20070037783A1 (en) | Migrastatin analogs and uses thereof | |
| JP2001514168A (en) | Antibacterial compound | |
| Ritter | Cholesterol-absorption inhibitors |